Compare · CHE vs SBC
CHE vs SBC
Side-by-side comparison of Chemed Corp (CHE) and SBC Medical Group Holdings Incorporated (SBC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and SBC operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.61B, about 17.0x SBC ($330.1M).
- Over the past year, CHE is down 25.7% and SBC is down 30.9% - CHE leads by 5.2 points.
- CHE has been more active in the news (11 items in the past 4 weeks vs 10 for SBC).
- CHE has more recent analyst coverage (6 ratings vs 1 for SBC).
- Company
- Chemed Corp
- SBC Medical Group Holdings Incorporated
- Price
- $423.21-0.74%
- $3.20-0.16%
- Market cap
- $5.61B
- $330.1M
- 1M return
- -0.58%
- -2.88%
- 1Y return
- -25.71%
- -30.89%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 11
- 10
- Recent ratings
- 6
- 1
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CHE
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
- Director Grace Patrick P was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,723 units (SEC Form 4)
- Director Delyons Ron was granted 386 units of Capital Stock, increasing direct ownership by 23% to 2,052 units (SEC Form 4)
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Latest SBC
- SEC Form DEFA14A filed by SBC Medical Group Holdings Incorporated
- SEC Form DEF 14A filed by SBC Medical Group Holdings Incorporated
- SBC Medical will participate in several upcoming investor conferences in May and June 2026
- SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
- SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Leadership Update
- Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
- SEC Form PRE 14A filed by SBC Medical Group Holdings Incorporated
- SEC Form 10-Q filed by SBC Medical Group Holdings Incorporated
- SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SBC Medical Group Holdings Announces First Quarter 2026 Financial Results